| Description |
1 online resource (453 p.) |
| Series |
Reproductive Medicine and Assisted Reproductive Techniques Ser |
|
Reproductive Medicine and Assisted Reproductive Techniques Ser
|
| Contents |
Cover -- Half Title -- Series -- Title -- Copyright -- Dedication -- Contents -- Foreword -- Preface -- About the Author -- 1. Epidemiology of Infertility, 21st-Century Considerations and the Covid-19 Pandemic -- 1.1 Introduction -- 1.2 Ovarian Ageing -- 1.3 At What Age Should Couples Start Trying for a Family? -- 1.4 Fertility Education -- 1.5 Measuring Infertility and Response to Treatment -- 1.6 Definition of Infertility -- 1.7 Is Infertility Becoming More Common? -- 1.8 Is Infertility on the Rise? -- 1.9 Principles of Infertility Treatment -- 1.10 Covid-19 and Fertility |
|
2. Prevention of Infertility -- 2.1 Introduction -- 2.2 Impact of Age on Male and Female Fertility -- 2.3 Can Women Protect Fertility against Ageing? -- 2.4 Contraception -- 2.5 Environmental Pollutants -- 2.6 Are Sperm Counts Falling? -- 2.7 Hypospadias, Cryptorchidism and Testicular Cancer -- 2.8 Conclusion -- 3. Planning a Pregnancy and Preconception Care -- 3.1 Introduction -- 3.2 A Preconception Healthcare Programme -- 3.3 Body Weight -- 3.4 Dietary Advice for Women Wishing to Conceive -- 3.5 Folic Acid (Folate) -- 3.6 Exercise -- 3.7 Supplements for Male Fertility |
|
3.8 Special Diets for Sex Selection -- 3.9 The Microbiome -- 3.10 Oral Health -- 3.11 Smoking, Alcohol and Recreational Drugs -- 3.12 Anabolic Androgenic Steroids -- 3.13 Acquired Infections -- 3.14 Medical Conditions and Drugs -- 3.15 Endocrine Disorders -- 3.16 Diabetes -- 3.17 Psychiatric Disorders -- 3.18 Neurological Disorders -- 3.19 Gastrointestinal Disease -- 3.20 Renal Disease -- 3.21 Cardiovascular Disease -- 3.22 Respiratory Disease -- 3.23 Antibiotics and Anti-Infective Agents -- 3.24 Haematological Problems -- 3.25 Connective Tissue Disorders -- 3.26 Chemotherapy |
|
4. Obesity and Reproduction -- 4.1 Introduction -- 4.2 Defining Obesity and the Extent of the Problem -- 4.3 Influence of Obesity on Natural Fertility -- 4.4 Obesity and Polycystic Ovary Syndrome -- 4.5 Effect of Obesity on Treatment of Anovulatory Infertility -- 4.6 Effect of Obesity on IVF and Related Treatments -- 4.7 Effect of Obesity on Pregnancy -- 4.8 Provision of Support in Achieving Weight Loss -- 4.9 Guidelines for Accessing Treatment -- 5 Investigating Infertility -- 5.1 Introduction -- 5.2 General Investigations -- 5.3 Investigating the Female Partner |
|
5.4 Diagnosis of Anovulatory Infertility -- 5.5 Endocrine Profile -- 5.6 Progesterone -- 5.7 Follicle-Stimulating Hormone -- 5.8 Ovarian Reserve Tests -- 5.9 Luteinising Hormone -- 5.10 Androgens -- 5.11 Thyroid Function -- 5.12 Prolactin -- 5.13 Oestrogen -- 5.14 Glucose Tolerance -- 5.15 Other Investigations -- 5.16 Pelvic Ultrasound -- 5.17 Ovarian Morphology -- 5.18 Differentiating between PCOM and PCOS -- 5.19 Ovarian Cysts -- 5.20 Endometrial Assessment -- 5.21 Doppler Ultrasound in Assisted Conception -- 5.22 Assessment of Tubal Patency and the Uterine Cavity |
| Notes |
Description based upon print version of record |
|
5.23 Ultrasound Contrast Hysterosalpingography or Hysterosalpingo Contrast Sonography |
| Form |
Electronic book
|
| ISBN |
9781000683363 |
|
1000683362 |
|
